Neuromeningeal cryptococcosis is a life-threatening infection of the central nervous system,
caused by encapsulated yeast belonging to the Cryptococcus neoformans and …

Infections with the human pathogenic basidiomycetous yeast Cryptococcus neoformans are
often treated with fluconazole. Resistance to this antifungal agent has been reported. This …

Strains of Cryptococcus neoformans expressing heteroresistance to fluconazole have been
described previously. The present study was conducted to investigate the prevalence of …

We analyzed 71 clinical and environmental Cryptococcus gattii strains that had been
isolated before or after the advent of azole antifungals to determine their level of …

Cryptococcus neoformans isolates that exhibited unusual patterns of resistance to
fluconazole and voriconazole were isolated from seven isolates from two different …

Eleven isolates of Cryptococcus neoformans were investigated to determine the biochemical
basis of their tolerance to fluconazole. The MICs of fluconazole for three isolates with low …

Cryptococcus sp. are responsible for around 1 million cases of meningitis every year.
Fluconazole (FLU) is commonly used in the treatment of cryptococcosis, mainly in …

Cryptococcosis is primarily caused by Cryptococcus neoformans and Cryptococcus gattii.
These two pathogenic species each divide into four distinct molecular genotypes. In this …

This study presents antifungal susceptibility data for environmental isolates of Cryptococcus
neoformans serotype A (n= 32) and Cryptococcus gattii serotype B (n= 18) to fluconazole …

Abstract Purpose of Study To review the literature on heteroresistance to fluconazole (FLC)
and investigate the level of heteroresistance to FLC (LHF), we analyzed 100 clinical and …